Barclays
XRAY icon

Barclays’s Dentsply Sirona XRAY Stock Holding History

Barclays’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,700
Closed -$606K – 6511
2019
Q4 		$606K Hold
10,700
– – ﹤0.01% 4124
2019
Q3 		$570K Buy
+10,700
New +$575K ﹤0.01% 4140
2018
Q4 		– Sell
-600
Closed -$23K – 7393
2018
Q3 		$23K Buy
+600
New +$25K ﹤0.01% 6431
2018
Q1 		– Sell
-40,400
Closed -$2.66M – 7373
2017
Q4 		$2.66M Buy
40,400
+400
+1% +$25.4K ﹤0.01% 2181
2017
Q3 		$2.39M Buy
+40,000
New +$2.38M ﹤0.01% 2161
2015
Q4 		– Sell
-900
Closed -$45K – 6661
2015
Q3 		$45K Buy
+900
New +$47.9K ﹤0.01% 5070
2015
Q2 		– Sell
-2,100
Closed -$105K – 7236
2015
Q1 		$105K Sell
2,100
-3,300
-61% -$170K ﹤0.01% 4823
2014
Q4 		$286K Buy
5,400
+200
+4% +$10.2K ﹤0.01% 4354
2014
Q3 		$234K Sell
5,200
-2,900
-36% -$136K ﹤0.01% 4608
2014
Q2 		$381K Sell
8,100
-13,400
-62% -$623K ﹤0.01% 4235
2014
Q1 		$989K Buy
21,500
+4,800
+29% +$222K ﹤0.01% 3248
2013
Q4 		$801K Buy
16,700
+16,500
+8,250% +$772K ﹤0.01% 3625
2013
Q3 		$9K Sell
200
-100
-33% -$4.27K ﹤0.01% 6828
2013
Q2 		$12K Buy
+300
New +$12.5K ﹤0.01% 7064

Other funds holding XRAY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Barclays's XRAY Position: Q2 2026 in Review

Barclays increased its Dentsply Sirona (XRAY) stake by 24% in Q2 2026, buying an estimated $359K and bringing the position to 171,836 shares worth $1.82M. The position accounts for ﹤0.01% of the portfolio, ranked #2398.

Barclays first reported a position in XRAY in Q2 2013 and has held it in 53 quarters since. The position peaked at $25M in Q1 2018. 374 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

  • Barclays held 171,836 shares of Dentsply Sirona worth $1.82M as of Q2 2026.
  • Barclays bought 32,925 Dentsply Sirona shares in Q2 2026, an estimated $359K.
  • Dentsply Sirona made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2398 holding.
  • Barclays first reported a position in Dentsply Sirona in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Dentsply Sirona position peaked at $25M in Q1 2018.
  • 374 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.